Sign In
Buy INCY
$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2020 Results - Earnings Call Transcript
03:29am, Wednesday, 05'th Aug 2020
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2020 Earnings Conference Call August 04, 2020 04:30 PM ET Company Participants Tom Galassi - Investor Relations Matt Coffey - President & Chief Executive O
Incyte (INCY) Gets a Hold Rating from Mizuho Securities - Markets
01:15am, Wednesday, 05'th Aug 2020
Mizuho Securities analyst Mara Goldstein assigned a Hold rating to Incyte (INCY – Research Report) yesterday and set a price
Leerink Partners Keeps a Hold Rating on Incyte (INCY) - Markets
09:40pm, Tuesday, 04'th Aug 2020
Leerink Partners analyst Andrew Berens maintained a Hold rating on Incyte (INCY – Research Report) today and set a price
Incyte Earnings Soar 65%, Easily Beating Views
08:11pm, Tuesday, 04'th Aug 2020
Incyte earnings and revenue rose much more than expected. The biotech reaffirmed guidance. INCY stock was not yet active early Tuesday.
Incyte Corp (INCY) Q2 2020 Earnings Call Transcript | The Motley Fool
07:00pm, Tuesday, 04'th Aug 2020
INCY earnings call for the period ending June 30, 2020.
Incyte (INCY) Beats on Q2 Earnings and Sales on Strong Jakafi
02:10pm, Tuesday, 04'th Aug 2020
Incyte (INCY) easily surpasses earnings and sales expectations in the second quarter as lead drug, Jakafi, reports strong growth.
Dow Jones Today Dips, Nasdaq Fights To Extend Streak; Take-Two, SolarEdge, AMD Rocket
01:58pm, Tuesday, 04'th Aug 2020
Take-Two, Inphi and Incyte rallied Tuesday, but stock futures dipped as the Dow Jones looked toward Disney's after-hours report.
Incyte (INCY) Q2 Earnings and Revenues Beat Estimates
12:45pm, Tuesday, 04'th Aug 2020
Incyte (INCY) delivered earnings and revenue surprises of 61.04% and 15.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Incyte Corporation (INCY) CEO Hervé Hoppenot on Q2 2020 Results - Earnings Call Transcript
12:22pm, Tuesday, 04'th Aug 2020
Incyte Corporation (INCY) CEO Hervé Hoppenot on Q2 2020 Results - Earnings Call Transcript
Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
11:00am, Tuesday, 04'th Aug 2020
Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte (INCY) Beats on Q2 Earnings and Sales on Strong Jakafi
10:10am, Tuesday, 04'th Aug 2020
Incyte (INCY) easily surpasses earnings and sales expectations in the second quarter as lead drug, Jakafi, reports strong growth.
Incyte (INCY) Q2 Earnings and Revenues Beat Estimates
08:45am, Tuesday, 04'th Aug 2020
Incyte (INCY) delivered earnings and revenue surprises of 61.04% and 15.50%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Incyte Earnings Soar 65%, Easily Beating Views
07:41am, Tuesday, 04'th Aug 2020
Incyte earnings and revenue rose much more than expected. The biotech reaffirmed guidance.
Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
07:00am, Tuesday, 04'th Aug 2020
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #earnings--Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
12:00am, Tuesday, 04'th Aug 2020
Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
